Provided by Tiger Trade Technology Pte. Ltd.

Travere Therapeutics, Inc.

64.74
+1.261.98%
Pre-market: 64.990.2500+0.39%04:58 EDT
Volume:1.38M
Turnover:89.51M
Market Cap:6.10B
PE:-135.88
High:65.86
Open:64.51
Low:63.84
Close:63.48
52wk High:68.73
52wk Low:22.06
Shares:94.26M
Float Shares:92.77M
Volume Ratio:0.87
T/O Rate:1.49%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.4764
EPS(LYR):-0.2864
ROE:-236.35%
ROA:-3.73%
PB:248.86
PE(LYR):-226.09

Loading ...

Mar 21, 2022

Major Issues Report

8-K - Current report
Mar 11, 2022

Major Issues Report

8-K - Current report
Mar 09, 2022

[Supp]Public Prospectus

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
Mar 09, 2022

[Supp]Public Prospectus

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
Feb 24, 2022

Major Issues Report

8-K - Current report
Feb 24, 2022

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 10, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 10, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 10, 2022

Major Issues Report

8-K - Current report
Jan 06, 2022

Major Issues Report

8-K - Current report
Dec 22, 2021

Major Issues Report

8-K - Current report
Dec 15, 2021

Major Issues Report

8-K - Current report
Oct 29, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 28, 2021

Major Issues Report

8-K - Current report
Oct 12, 2021

Major Issues Report

8-K - Current report